No Data
No Data
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
12 Health Care Stocks Moving In Wednesday's After-Market Session
Leerink Partners Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating
LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $9
Eledon Pharmaceuticals Reports Positive Data in Type 1 Diabetes Study; Shares Rise
Express News | Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
No Data
No Data